Table 2 Excellent responders (group A vs groups B and C) with respect to demographic and clinical characteristics
Groups B and C (19) | Group A (excellent responders) (58) | P value | |
|---|---|---|---|
Age | 0.624 | ||
< 1 year | 11 | 29 | |
1–2 years | 4 | 10 | |
> 2 years | 4 | 19 | |
Gender | 0.391 | ||
Male | 11 | 27 | |
Female | 8 | 31 | |
Swelling | 0.738 | ||
Yes | 13 | 42 | |
No | 6 | 16 | |
Pain | 0.827 | ||
Yes | 7 | 23 | |
No | 12 | 35 | |
Disfigurement | 0.014 | ||
Yes | 15 | 27 | |
No | 4 | 31 | |
Discoloration | 0.04 | ||
Yes | 14 | 27 | |
No | 5 | 31 | |
Bleeding | 0.956 | ||
Yes | 8 | 24 | |
No | 11 | 34 | |
Limited motion | 0.713 | ||
Yes | 2 | 8 | |
No | 17 | 50 | |
Morphological subtypes | < 0.001 | ||
Macrocystic LMs | 0 | 31 | |
Microcystic LMs | 12 | 9 | |
Mixed LMs (macrocystic and microcystic) | 7 | 18 | |
Extent | < 0.001 | ||
Focal | 9 | 53 | |
Diffuse | 10 | 5 |